DBT Biotech Industry Partnership Programme

DBT BIPP sits under the Department of Biotechnology and BIRAC as the larger industry-partnership route in India's biotech stack. It backs path-breaking research in frontier technology areas on a cost-sharing basis, so the money is tied to a commercial partner rather than a pure subsidy model. The programme is a grant with a ceiling of INR 25 crore per project, including equipment, and approved projects usually run two to four years. It is currently open on a rolling basis, and the 2025 guidelines also note a separate provision for start-ups that have not previously received BIRAC funding. BIPP suits high-risk biotechnology programmes that already have an industry partner and a milestone plan. The strongest proposals are deep technical bets with a clear development path, because the scheme is designed to support frontier research that can still move toward a product or platform. Because the scheme is milestone driven, applicants usually need an industry partner, a clear timetable, and enough internal capacity to carry the project after award.

No upcoming rounds verified. Cadence: Annual.